Help shape and execute the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm.
Base: $193,898 to $290,847; Bonus/Equity: eligibility for short-term incentive bonuses, equity-based awards; Benefits: qualified retirement programs, paid time off, health, dental, and vision coverage
Must-have
Nice-to-have
Not specified